Abstract:Objective: To analyze the pathological features of patients with osteosarcoma and the correlation of expressions of transferrin receptor 1 (TfR1), vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 in tumor tissue with the pathological features. Methods: The tumor tissue and paracancerous tissue samples from 31 patients with osteosarcoma were collected before treatment to measure the expressions of TfR1, VEGF and MMP-9. Kaplan-meier curve was used to analyze the relationship of TfR1, VEGF and MMP-9 with the survival time of patients. Log-rank test was used to test the difference, and Spearman test was used to test the correlation. Results: Among the 31 osteosarcoma samples, 23 (74.19%), 24 (77.42%) and 17 (54.84%) samples showed medium-high expressions of VEGF, TfR1 and MMP-9, respectively, which were significantly higher than those in the paracancerous samples (P<0.05). Furthemore, the medium-high expression rates of VEGF, TfR1 and MMP-9 were significantly different in patients with different Enneking stages, different histological differentiation degrees, and with or without distant metastasis. Besides, the expression of VEGF was also significantly different in different-size osteosarcoma samples (P<0.05). The survival time of patients with low expressions of TfR1, VEGF and MMP-9 was significantly longer than that of patients with medium-high expressions (P<0.05). Additionally, in osteosarcoma samples, significant positive correlations were shown between the expressions of TfR1 and VEGF, as well as between TfR1 and MMP-9 (P<0.05), but there was no significant correlation between VEGF and MMP-9 (P>0.05). Conclusion: TfR1, VEGF and MMP-9 are abnormally expressed in osteosarcoma lesions, suggesting that they all play a role in the occurrence and development of osteosarcoma.

The expression of KAI-1, Osteopontin (OPN) and their clinicopathological significance in osteochon- droma and malignant bone tumors

The expression of tumor metastasis suppressor gene KAI1 and matrix metalloproteinase 2 in breast cancer tissues

Expression of SKP2,p27 and their clinicopathological significance in osteochondroma and malignant bone tumors

The detection of osteopontin and matrix metalloproteinase-9 expression in non-small cell lung cancer using tissue microarray techniqe and its clinical significance

[The Expression of Noncollagenous Proteins and the Tumor Differentiation in Oral Maxillofacial Osteosarcoma].

The expression of osteopontin(OPN) in ovarian tumors and its association with malignancy

The Expression of KAI1 Metastasis Suppressor Gene in Cervical Squamous Cell Carcinoma and Its Clinical Significance

Association Between Expression of Nuclear Receptor Co-Activator 5 Protein and Prognosis in Postoperative Patients with Osteosarcoma

Expressions of OPG and OPGL in Osteosarcoma and Their Significance

The expression of OPN in hepatocellular carcinoma and their clinical significance

Expression of osteopontin and NF-кB p65 in non-small cell lung cancer

Clinical Significance of the Expression of Osteopontin and MMP-9 in Breast Cancer

Expression of KAI-1 mRNA, Kiss-1 mRNA and MTA1 in benign and malignant lesions of breast and its clinicopathological significance

Expression of KAI1 and MMP-9 Protein and Its Relationship with Invasion and Metastasis of Gastric Carcinoma

Expression and Significance of Osteopontin and MMP-2 in Non-Small Cell Lung Cancer

Quantitative analysis and significance of osteopontin expression in oral squamous cell carcinoma

The Clinical Significance of KAI1/CD82 Expression in Colon Tumor

Study on the Expression and Significance of OPN and OCT2 in Human Gastric Carcinoma

Analysis of clinical significance of p27 and OPN in Prostate cancer tissues

Expression of KAI1 and MMP-9 protein and relationship with invasion and metastasis of breast carcinoma

Correlation Between Pathological Features and Protein Expressions of TfR1, VEGF and MMP-9 in Patients with Osteosarcoma